Task: Answer the following question about the molecule with SMILES CCP(=S)(Oc1ccc([N+](=O)[O-])cc1Cl)OC(C)C.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Phase 2 Clinical Trials
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCP(=S)(Oc1ccc([N+](=O)[O-])cc1Cl)OC(C)C
CCP(=S)(Oc1ccc([N+](=O)[O-])cc1Cl)OC(C)C
(6-chloro-4-nitrocyclohexa-1,3,5-trien-1-yl)oxy-ethyl-propan-2-yloxy-sulfanylidene-λ5-phosphane
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.